These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37682324)
1. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study. Jiang S; Lu X; Wei R; Zhang A; Chen H; Shi W; Xia L Ann Hematol; 2023 Nov; 102(11):3205-3216. PubMed ID: 37682324 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation]. Xu Y; Zhang J; Xue SL; Miao M; Wang Y; Chen SN; Qiu HY; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):357-363. PubMed ID: 38951063 [No Abstract] [Full Text] [Related]
3. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification]. Wang H; Ma RZ; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):445-452. PubMed ID: 38964918 [No Abstract] [Full Text] [Related]
5. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China. Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789 [TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome-evolved acute myeloid leukemia]. Chen SL; Shi YY; Zhang LN; Gong M; Zhang XY; Zhao XL; Hao MZ; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):364-369. PubMed ID: 38951064 [No Abstract] [Full Text] [Related]
7. [Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation]. Zhang F; Wang HF; Hu GH; Suo P; Bai L; Wang Y; Zhang XH; Huang XJ; Cheng YF Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):832-837. PubMed ID: 39414606 [No Abstract] [Full Text] [Related]
9. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation-A Comprehensive Single Center Retrospective Analysis. Neuerburg CKF; Schmitz F; Schmitz MT; Rehnelt S; Schumacher M; Parčina M; Schmid M; Wolf D; Brossart P; Holderried TAW Transplant Cell Ther; 2024 Dec; 30(12):1195.e1-1195.e13. PubMed ID: 39299503 [TBL] [Abstract][Full Text] [Related]
11. Infliximab for maintenance of medically-induced remission in Crohn's disease. Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
13. Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation. Nozzoli C; Pucillo M; Giaccone L; Rambaldi A; Stanghellini MTL; Benedetti E; Russo D; Mordini N; Mangiacavalli S; Bernasconi P; Parma M; Carluccio P; Galieni P; Rivela P; Martino M; Chiusolo P; Isola M; De Martino M; Oldani E; Degrandi E; Boncompagni R; Antonioli E; Carnevale F; Tozzi M; Selleri C; Fanin R; Patriarca F; Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39505212 [TBL] [Abstract][Full Text] [Related]
14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
15. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia]. Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596 [No Abstract] [Full Text] [Related]
17. Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. Wang Q; Liang Z; Ren H; Dong Y; Yin Y; Wang Q; Liu W; Wang B; Han N; Li Y; Li Y Ann Hematol; 2023 Nov; 102(11):3061-3074. PubMed ID: 37667046 [TBL] [Abstract][Full Text] [Related]
18. Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS. Radford M; Garcia-Horton A; Badami R; Jin E; Usmani N; Grafodatskaya D; McCready E; Khalaf D; Walker I; Leber B; Lepic K; Pond G; Berg T Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39547311 [TBL] [Abstract][Full Text] [Related]
19. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways. Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460 [TBL] [Abstract][Full Text] [Related]